Collaboration of RON and Epidermal Growth Factor Receptor in Human Bladder Carcinogenesis

Journal of Urology

Volumn 176, Issue 5, 2006, Pages 1909-1910

  Thomas, Christopher Y ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LAPATINIB;

BLADDER CARCINOMA; CARCINOGENESIS; CLINICAL TRIAL; CORRELATION ANALYSIS; EDITORIAL; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR REGRESSION;

HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; URINARY BLADDER NEOPLASMS;

EID: 33750379826     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.048     Document Type: Editorial

References (8)

1. Knowles M.A. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?. Carcinogenesis 27 (2006) 361
2. Santoro M.M., Penengo L., Minetto M., Orecchia S., Cilli M., and Gaudino G. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Oncogene 17 (1998) 741
3. Fischer O.M., Hart S., Gschwind A., and Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31 (2003) 1203
4. Danilkovitch-Miagkova A., and Leonard E.J. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors. Histol Histopathol 16 (2001) 623
5. Peace B.E., Hill K.J., Degen S.J., and Waltz S.E. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor. Exp Cell Res 289 (2003) 317
6. Wulfing C., Machiels J.-P., Richel D., Grimm M.-O., Treiber U., de Groot M., et al. A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. J Clin Oncol 2005 ASCO Annual Meeting Proceedings 23 (2005) abstract 4594
7. Cheng H.L., Liu H.S., Lin Y.J., Chen H.H., Hsu P.Y., Chang T.Y., et al. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder. Br J Cancer 92 (2005) 1906
8. Abraham S., Knapp D.W., Cheng L., Snyder P.W., Mittal S.K., Bangari D.S., et al. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res 12 (2006) 353